Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Oncology R&D Pipeline

Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Programs 5,539

Quick answer

Oncology: NovaPharmaNews indexes 5,539 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Top sponsors

Pipeline programs

Page 25 of 116

  1. ZD6474 (vandetanib)

    Sanofi Pasteur

    Non-Small-Cell Lung Carcinoma

    phase 3 small molecule completed

    1 trial

  2. ZWI-ZW25-301

    Jazz Pharmaceuticals Ireland Limited

    Gastroesophageal Adenocarcinoma (GEA)

    phase 3 small molecule active

    1 trial

  3. Zanidatamab

    Jazz Pharmaceuticals Ireland Limited

    Metastatic HER2-positive Breast Cancer

    phase 3 small molecule active

    1 trial

  4. Zanidatamab

    BEONE MEDICINES AUS PTY LTD

    Gastric Neoplasms

    phase 3 small molecule active

    1 trial

  5. Zanidatamab

    Jazz Pharmaceuticals Ireland Limited

    Biliary Tract Cancer

    phase 3 small molecule active

    1 trial

  6. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    2 trials

  7. Zanubrutinib

    BeiGene

    Chronic Lymphocytic Leukemia

    phase 3 small molecule completed

    1 trial

  8. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory Follicular Lymphoma

    phase 3 small molecule active

    1 trial

  9. Ziftomenib

    Kura Oncology

    Acute Myeloid Leukemia (AML)

    phase 3 small molecule active

    1 trial

  10. Zilovertamab vedotin

    Merck KGaA, Darmstadt, Germany

    Diffuse Large B-Cell Lymphoma

    phase 3 mab active

    1 trial

  11. Zimberelimab

    Arcus Biosciences

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    2 trials

  12. Zoledronic acid

    Novartis Pharmaceuticals

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  13. Zometa 4 mg/100 ml solution for infusion

    Ningbo Cancer Hospital

    High grade osteosarcoma

    phase 3 small molecule active

    1 trial

  14. [18F]-AlF-FAPI-74

    Disc Medicine

    Carcinoma of Unknown Primary

    phase 3 small molecule active

    1 trial

  15. [18F]-AlF-FAPI-74

    Disc Medicine

    Advanced gastric cancer

    phase 3 small molecule active

    1 trial

  16. [18F]-AlF-FAPI-74 for Cholangiocarcinoma

    Disc Medicine

    Cholangiocarcinoma

    phase 3 small molecule active

    1 trial

  17. [68Ga]Ga-PentixaFor, FLUDEOXYGLUCOSE (18F)

    Alphapharm Pty Ltd

    Marginal Zone Lymphoma

    phase 3 small molecule active

    1 trial

  18. a patient self-reporting applet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cancer Pain

    phase 3 other active

    1 trial

  19. adoptive immunotherapy

    Chinese PLA General Hospital

    Hepatocellular Carcinoma

    phase 3 mab completed

    1 trial

  20. asparaginase

    United Therapeutics Europe Ltd

    Lymphoma

    phase 3 small molecule active

    1 trial

  21. asparaginase

    Children's Hospital of Fudan University

    Leukemia

    phase 3 small molecule completed

    2 trials

  22. bempegaldesleukin

    Nektar Therapeutics UK Limited

    Renal Cell Carcinoma

    phase 3 mab terminated

    1 trial

  23. bendamustine

    Teva Pharma GmbH

    Non-Hodgkin's Lymphoma

    phase 3 small molecule completed

    2 trials

  24. bexarotene

    Eisai Co.,

    Non-small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  25. brentuximab vedotin

    Takeda

    Hodgkin Lymphoma

    phase 3 small molecule completed

    3 trials

  26. brigatinib

    Takeda

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    2 trials

  27. canakinumab

    Novartis Pharmaceuticals

    Non-small Cell Lung Cancer

    phase 3 small molecule terminated

    2 trials

  28. cemiplimab

    Regeneron UK Limited

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    3 trials

  29. cetuximab + cisplatin + vinorelbine

    Merck KGaA, Darmstadt, Germany

    Non Small Cell Lung Cancer (NSCLC)

    phase 3 small molecule completed

    1 trial

  30. chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Limited Stage Small Cell Lung Cancer

    phase 3 other active

    1 trial

  31. cisplatin

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 3 small molecule completed

    1 trial

  32. cisplatin

    Pari Pharma GmbH

    Lung Cancer

    phase 3 small molecule completed

    1 trial

  33. cisplatin i.p.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epithelial Carcinoma, Ovarian

    phase 3 small molecule active

    1 trial

  34. custirsen sodium

    Teva Pharma GmbH

    Castrate-Resistant Prostate Cancer

    phase 3 small molecule terminated

    1 trial

  35. cyclophosphamide

    Partner Therapeutics Limited

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  36. cyclosporine

    Takeda

    Leukemia

    phase 3 small molecule terminated

    1 trial

  37. dactinomycin

    Children's Hospital of Fudan University

    Kidney Cancer

    phase 3 mab completed

    1 trial

  38. dactinomycin

    Solid Biosciences

    Sarcoma

    phase 3 mab active

    1 trial

  39. daraxonrasib

    Revolution Medicines

    NSCLC (Non-small Cell Lung Cancer)

    phase 3 small molecule active

    1 trial

  40. daraxonrasib

    Revolution Medicines

    Pancreatic Cancer

    phase 3 small molecule active

    2 trials

  41. decitabine

    The First People's Hospital of Lianyungang

    Acute Myelocytic Leukemia

    phase 3 small molecule active

    1 trial

  42. desiccated thyroid extract (DTE)+levothyroxine (L-T4)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intermediate-to-High Risk Differentiated Thyroid Cancer

    phase 3 small molecule active

    1 trial

  43. doxorubicin hydrochloride

    Children's Hospital of Fudan University

    Adult Alveolar Soft-part Sarcoma

    phase 3 small molecule completed

    1 trial

  44. doxorubicin hydrochloride

    United Therapeutics Europe Ltd

    Stage III Bladder Cancer

    phase 3 small molecule completed

    1 trial

  45. doxorubicin in combination with palifosfamide-tris

    Alaunos Therapeutics

    Soft Tissue Sarcoma

    phase 3 small molecule completed

    1 trial

  46. educational internet site on prostate cancer screening

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 3 other completed

    1 trial

  47. erlotinib

    Hoffmann-La Roche

    Non-Squamous Non-Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  48. esophagectomy

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 3 other active

    1 trial

Frequently asked questions

How many oncology pipeline programs are tracked?

5,539 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.